Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Urinary System Drugs >  Diuretics Drugs >  5-(N,N-HEXAMETHYLENE)-AMILORIDE

5-(N,N-HEXAMETHYLENE)-AMILORIDE

Basic information Safety Supplier Related

5-(N,N-HEXAMETHYLENE)-AMILORIDE Basic information

Product Name:
5-(N,N-HEXAMETHYLENE)-AMILORIDE
Synonyms:
  • 5-(N,N-HEXAMETHYLENE)-AMILORIDE
  • AMILORIDE,5-(N,N-HEXAMETHYLENE)-
  • 3-AMINO-N-(AMINOIMINOMETHYL)-6-CHLORO-5-(HEXAHYDRO-1H-AZEPIN-1-YL)-PYRAZINE-CARBOXAMIDE
  • AMILORIDE, 5-(N,N-HEXAMETHYLENE) >93% NA +/H+ ANTIPORTER INH
  • hma
  • amipromizide
  • 3-Amino-5-(1-azacycloheptane-1-yl)-6-chloro-N-(aminoiminomethyl)pyrazine-2-carboxamide
  • 3-Amino-5-(hexahydro-1H-azepin-1-yl)-6-chloro-N-(aminoiminomethyl)-2-pyrazinecarboxamide
CAS:
1428-95-1
MF:
C12H18ClN7O
MW:
311.77
Mol File:
1428-95-1.mol
More
Less

5-(N,N-HEXAMETHYLENE)-AMILORIDE Chemical Properties

Melting point:
224-225 °C
Density 
1.63±0.1 g/cm3(Predicted)
storage temp. 
2-8°C
solubility 
DMF: 3mg/mL; DMSO: 10mg/mL; DMSO:PBS (pH 7.2) (1:4): 0.2mg/mL
form 
A crystalline solid
pka
8.81±0.46(Predicted)
color 
Light yellow to yellow
More
Less

Safety Information

Hazard Codes 
T
Risk Statements 
23/24/25
Safety Statements 
22-36/37/39-45
RIDADR 
2811
WGK Germany 
3
HazardClass 
6.1(b)
PackingGroup 
III

MSDS

More
Less

5-(N,N-HEXAMETHYLENE)-AMILORIDE Usage And Synthesis

Description

5-(N,N-hexamethylene)-Amiloride (HMA) is a derivative of amiloride with diverse biological activities. It is an allosteric antagonist of adenosine A2A receptors (Ki = 3.3 μM). HMA inhibits the cation-selective ion channel formed by the HIV-1 viral protein Vpu when used at a concentration of 50 μM, as well as budding of virus-like particles in HeLa cells expressing the HIV-1 proteins Gag and Vpu when used at a concentration of 10 μM. It also blocks the cation-selective ion channels formed by the hepatitis C virus (HCV) protein p7. HMA (40 μM) induces necrosis in and reduces the viability of MCF-7, MDA-MB-231, T47D, SK-BR-3, Met-1, and NDL breast cancer cells but not cardiomyocytes or uterine, pulmonary, and renal epithelial cells. HMA protects against post-ischemic contractile dysfunction and reduces coronary effluent creatine phosphokinase activity in a model of ischemia-reperfusion injury using isolated rat right ventricular free walls.

Definition

ChEBI: A member of the class of pyrazines that is amiloride in which the two amino hydrogens at position N-5 are replaced by a hexamethylene moiety, resulting in the formation of an azepane ring.

Biochem/physiol Actions

Inhibitor of Na+/H+ antiport.

5-(N,N-HEXAMETHYLENE)-AMILORIDESupplier

HangZhou YuHao Chemical Technology Co., Ltd.
Tel
0571-82693216
Email
info@yuhaochemical.com
Sigma-Aldrich
Tel
021-61415566 800-8193336
Email
orderCN@merckgroup.com
Beijing Solarbio Science & Tecnology Co., Ltd.
Tel
010-50973130 4009686088
Email
3193328036@qq.com
Beijing Jin Ming Biotechnology Co., Ltd.
Tel
010-60605840 18892239720
Email
psaitong@jm-bio.com
Shenzhen SUNGENING Bio-Medical Co., Ltd.
Tel
0755-28967200 13631290199
Email
wxf@sungening.com